Home › Trial NCT06283719
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer
- Trial IDNCT06283719
- StatusRecruiting
- PhasePhase 1/2
- Study typeInterventional
- SponsorSuzhou Zelgen Biopharmaceuticals Co.,Ltd
- Enrollment265
- Start date2024-09-02
- ConditionsSmall Cell Lung Cancer · Neuroendocrine Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.